Global Healthcare-Acquired Infection Market Research Report 2023

The healthcare-acquired infection is a new infection that develops in a patient during hospitalization.

The global Healthcare-Acquired Infection market was valued at US$ 26230 million in 2022 and is anticipated to reach US$ 40550 million by 2029, witnessing a CAGR of 7.5% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Healthcare-Acquired Infection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Healthcare-Acquired Infection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Healthcare-Acquired Infection in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Healthcare-Acquired Infection include Pfizer, Novartis, Roche, Sanofi, Abbott, BD and Hologic, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Healthcare-Acquired Infection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare-Acquired Infection.

The Healthcare-Acquired Infection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Healthcare-Acquired Infection market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Healthcare-Acquired Infection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Healthcare-Acquired Infection Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Pharmaceutical Treatment

1.2.3 Environment Treatment

1.2.4 Medical Devices Management

1.3 Market by Application

1.3.1 Global Healthcare-Acquired Infection Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Ambulatory Surgery Centers

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Healthcare-Acquired Infection Market Perspective (2018-2029)

2.2 Healthcare-Acquired Infection Growth Trends by Region

2.2.1 Global Healthcare-Acquired Infection Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Healthcare-Acquired Infection Historic Market Size by Region (2018-2023)

2.2.3 Healthcare-Acquired Infection Forecasted Market Size by Region (2024-2029)

2.3 Healthcare-Acquired Infection Market Dynamics

2.3.1 Healthcare-Acquired Infection Industry Trends

2.3.2 Healthcare-Acquired Infection Market Drivers

2.3.3 Healthcare-Acquired Infection Market Challenges

2.3.4 Healthcare-Acquired Infection Market Restraints

3.1 Global Top Healthcare-Acquired Infection Players by Revenue

3.1.1 Global Top Healthcare-Acquired Infection Players by Revenue (2018-2023)

3.1.2 Global Healthcare-Acquired Infection Revenue Market Share by Players (2018-2023)

3.2 Global Healthcare-Acquired Infection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Healthcare-Acquired Infection Revenue

3.4 Global Healthcare-Acquired Infection Market Concentration Ratio

3.4.1 Global Healthcare-Acquired Infection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Healthcare-Acquired Infection Revenue in 2022

3.5 Healthcare-Acquired Infection Key Players Head office and Area Served

3.6 Key Players Healthcare-Acquired Infection Product Solution and Service

3.7 Date of Enter into Healthcare-Acquired Infection Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Healthcare-Acquired Infection Historic Market Size by Type (2018-2023)

4.2 Global Healthcare-Acquired Infection Forecasted Market Size by Type (2024-2029)

5.1 Global Healthcare-Acquired Infection Historic Market Size by Application (2018-2023)

5.2 Global Healthcare-Acquired Infection Forecasted Market Size by Application (2024-2029)

6.1 North America Healthcare-Acquired Infection Market Size (2018-2029)

6.2 North America Healthcare-Acquired Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Healthcare-Acquired Infection Market Size by Country (2018-2023)

6.4 North America Healthcare-Acquired Infection Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Healthcare-Acquired Infection Market Size (2018-2029)

7.2 Europe Healthcare-Acquired Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Healthcare-Acquired Infection Market Size by Country (2018-2023)

7.4 Europe Healthcare-Acquired Infection Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Healthcare-Acquired Infection Market Size (2018-2029)

8.2 Asia-Pacific Healthcare-Acquired Infection Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Healthcare-Acquired Infection Market Size by Region (2018-2023)

8.4 Asia-Pacific Healthcare-Acquired Infection Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Healthcare-Acquired Infection Market Size (2018-2029)

9.2 Latin America Healthcare-Acquired Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Healthcare-Acquired Infection Market Size by Country (2018-2023)

9.4 Latin America Healthcare-Acquired Infection Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Healthcare-Acquired Infection Market Size (2018-2029)

10.2 Middle East & Africa Healthcare-Acquired Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Healthcare-Acquired Infection Market Size by Country (2018-2023)

10.4 Middle East & Africa Healthcare-Acquired Infection Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Healthcare-Acquired Infection Introduction

11.1.4 Pfizer Revenue in Healthcare-Acquired Infection Business (2018-2023)

11.1.5 Pfizer Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Healthcare-Acquired Infection Introduction

11.2.4 Novartis Revenue in Healthcare-Acquired Infection Business (2018-2023)

11.2.5 Novartis Recent Development

11.3 Roche

11.3.1 Roche Company Detail

11.3.2 Roche Business Overview

11.3.3 Roche Healthcare-Acquired Infection Introduction

11.3.4 Roche Revenue in Healthcare-Acquired Infection Business (2018-2023)

11.3.5 Roche Recent Development

11.4 Sanofi

11.4.1 Sanofi Company Detail

11.4.2 Sanofi Business Overview

11.4.3 Sanofi Healthcare-Acquired Infection Introduction

11.4.4 Sanofi Revenue in Healthcare-Acquired Infection Business (2018-2023)

11.4.5 Sanofi Recent Development

11.5 Abbott

11.5.1 Abbott Company Detail

11.5.2 Abbott Business Overview

11.5.3 Abbott Healthcare-Acquired Infection Introduction

11.5.4 Abbott Revenue in Healthcare-Acquired Infection Business (2018-2023)

11.5.5 Abbott Recent Development

11.6 BD

11.6.1 BD Company Detail

11.6.2 BD Business Overview

11.6.3 BD Healthcare-Acquired Infection Introduction

11.6.4 BD Revenue in Healthcare-Acquired Infection Business (2018-2023)

11.6.5 BD Recent Development

11.7 Hologic

11.7.1 Hologic Company Detail

11.7.2 Hologic Business Overview

11.7.3 Hologic Healthcare-Acquired Infection Introduction

11.7.4 Hologic Revenue in Healthcare-Acquired Infection Business (2018-2023)

11.7.5 Hologic Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Healthcare-Acquired Infection Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Pharmaceutical Treatment

    Table 3. Key Players of Environment Treatment

    Table 4. Key Players of Medical Devices Management

    Table 5. Global Healthcare-Acquired Infection Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Healthcare-Acquired Infection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Healthcare-Acquired Infection Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Healthcare-Acquired Infection Market Share by Region (2018-2023)

    Table 9. Global Healthcare-Acquired Infection Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Healthcare-Acquired Infection Market Share by Region (2024-2029)

    Table 11. Healthcare-Acquired Infection Market Trends

    Table 12. Healthcare-Acquired Infection Market Drivers

    Table 13. Healthcare-Acquired Infection Market Challenges

    Table 14. Healthcare-Acquired Infection Market Restraints

    Table 15. Global Healthcare-Acquired Infection Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Healthcare-Acquired Infection Market Share by Players (2018-2023)

    Table 17. Global Top Healthcare-Acquired Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-Acquired Infection as of 2022)

    Table 18. Ranking of Global Top Healthcare-Acquired Infection Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Healthcare-Acquired Infection Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Healthcare-Acquired Infection Product Solution and Service

    Table 22. Date of Enter into Healthcare-Acquired Infection Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Healthcare-Acquired Infection Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Healthcare-Acquired Infection Revenue Market Share by Type (2018-2023)

    Table 26. Global Healthcare-Acquired Infection Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Healthcare-Acquired Infection Revenue Market Share by Type (2024-2029)

    Table 28. Global Healthcare-Acquired Infection Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Healthcare-Acquired Infection Revenue Market Share by Application (2018-2023)

    Table 30. Global Healthcare-Acquired Infection Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Healthcare-Acquired Infection Revenue Market Share by Application (2024-2029)

    Table 32. North America Healthcare-Acquired Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Healthcare-Acquired Infection Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Healthcare-Acquired Infection Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Healthcare-Acquired Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Healthcare-Acquired Infection Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Healthcare-Acquired Infection Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Healthcare-Acquired Infection Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Healthcare-Acquired Infection Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Healthcare-Acquired Infection Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Healthcare-Acquired Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Healthcare-Acquired Infection Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Healthcare-Acquired Infection Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Healthcare-Acquired Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Healthcare-Acquired Infection Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Healthcare-Acquired Infection Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Pfizer Company Detail

    Table 48. Pfizer Business Overview

    Table 49. Pfizer Healthcare-Acquired Infection Product

    Table 50. Pfizer Revenue in Healthcare-Acquired Infection Business (2018-2023) & (US$ Million)

    Table 51. Pfizer Recent Development

    Table 52. Novartis Company Detail

    Table 53. Novartis Business Overview

    Table 54. Novartis Healthcare-Acquired Infection Product

    Table 55. Novartis Revenue in Healthcare-Acquired Infection Business (2018-2023) & (US$ Million)

    Table 56. Novartis Recent Development

    Table 57. Roche Company Detail

    Table 58. Roche Business Overview

    Table 59. Roche Healthcare-Acquired Infection Product

    Table 60. Roche Revenue in Healthcare-Acquired Infection Business (2018-2023) & (US$ Million)

    Table 61. Roche Recent Development

    Table 62. Sanofi Company Detail

    Table 63. Sanofi Business Overview

    Table 64. Sanofi Healthcare-Acquired Infection Product

    Table 65. Sanofi Revenue in Healthcare-Acquired Infection Business (2018-2023) & (US$ Million)

    Table 66. Sanofi Recent Development

    Table 67. Abbott Company Detail

    Table 68. Abbott Business Overview

    Table 69. Abbott Healthcare-Acquired Infection Product

    Table 70. Abbott Revenue in Healthcare-Acquired Infection Business (2018-2023) & (US$ Million)

    Table 71. Abbott Recent Development

    Table 72. BD Company Detail

    Table 73. BD Business Overview

    Table 74. BD Healthcare-Acquired Infection Product

    Table 75. BD Revenue in Healthcare-Acquired Infection Business (2018-2023) & (US$ Million)

    Table 76. BD Recent Development

    Table 77. Hologic Company Detail

    Table 78. Hologic Business Overview

    Table 79. Hologic Healthcare-Acquired Infection Product

    Table 80. Hologic Revenue in Healthcare-Acquired Infection Business (2018-2023) & (US$ Million)

    Table 81. Hologic Recent Development

    Table 82. Research Programs/Design for This Report

    Table 83. Key Data Information from Secondary Sources

    Table 84. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Healthcare-Acquired Infection Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Healthcare-Acquired Infection Market Share by Type: 2022 VS 2029

    Figure 3. Pharmaceutical Treatment Features

    Figure 4. Environment Treatment Features

    Figure 5. Medical Devices Management Features

    Figure 6. Global Healthcare-Acquired Infection Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Healthcare-Acquired Infection Market Share by Application: 2022 VS 2029

    Figure 8. Hospital Case Studies

    Figure 9. Clinics Case Studies

    Figure 10. Ambulatory Surgery Centers Case Studies

    Figure 11. Others Case Studies

    Figure 12. Healthcare-Acquired Infection Report Years Considered

    Figure 13. Global Healthcare-Acquired Infection Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Healthcare-Acquired Infection Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Healthcare-Acquired Infection Market Share by Region: 2022 VS 2029

    Figure 16. Global Healthcare-Acquired Infection Market Share by Players in 2022

    Figure 17. Global Top Healthcare-Acquired Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-Acquired Infection as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Healthcare-Acquired Infection Revenue in 2022

    Figure 19. North America Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Healthcare-Acquired Infection Market Share by Country (2018-2029)

    Figure 21. United States Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Healthcare-Acquired Infection Market Share by Country (2018-2029)

    Figure 25. Germany Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Healthcare-Acquired Infection Market Share by Region (2018-2029)

    Figure 33. China Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Healthcare-Acquired Infection Market Share by Country (2018-2029)

    Figure 41. Mexico Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Healthcare-Acquired Infection Market Share by Country (2018-2029)

    Figure 45. Turkey Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Healthcare-Acquired Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Pfizer Revenue Growth Rate in Healthcare-Acquired Infection Business (2018-2023)

    Figure 48. Novartis Revenue Growth Rate in Healthcare-Acquired Infection Business (2018-2023)

    Figure 49. Roche Revenue Growth Rate in Healthcare-Acquired Infection Business (2018-2023)

    Figure 50. Sanofi Revenue Growth Rate in Healthcare-Acquired Infection Business (2018-2023)

    Figure 51. Abbott Revenue Growth Rate in Healthcare-Acquired Infection Business (2018-2023)

    Figure 52. BD Revenue Growth Rate in Healthcare-Acquired Infection Business (2018-2023)

    Figure 53. Hologic Revenue Growth Rate in Healthcare-Acquired Infection Business (2018-2023)

    Figure 54. Bottom-up and Top-down Approaches for This Report

    Figure 55. Data Triangulation

    Figure 56. Key Executives Interviewed